Insights & News

Insights & News

On October 26, our firm held a webinar dedicated to the current legal trends and regulatory changes in the pharmaceutical and healthcare industry, which companies may face in Russia. Dur...
30 October 2023 Firm news
We are glad to present you with an overview of the Russian regulations in the sphere of pharmaceuticals and life sciences for the 1st half of 2023. There are several digital initiatives ...
17 July 2023 Newsletters
On March 16th our firm held a webinar dedicated to the current legal trends in the pharmaceutical and healthcare industry, which Life Sciences companies may face in Russia. The experts p...
17 March 2023 Firm news
We are glad to present you a current digest of the most significant bills, regulatory changes, and measures affecting the pharmaceutical and healthcare industry for the period from June t...
01 November 2022 Newsletters
We would like to inform you that the Russian President has signed amendments to Article 1360 the Civil Code of the Russian Federation ('Russian Civil Code'), in terms of providing compuls...
20 May 2021 Newsletters
We would like to inform you about several important news items, in the pharmaceutical industry, at the beginning of 2021. The Rules of registration and assessment of medicines for medica...
11 February 2021 Newsletters
On September 18th, 2020, the Federal Service for Surveillance in Healthcare (Roszdravnadzor) adopted a new Order approving the criteria for blocking the websites with the content infringi...
02 October 2020 Newsletters
ALRUD has once again taken high positions in M&A, Banking, Capital Markets, Restructuring and Insolvency, Project Finance and Project Development (Mining, Power, PPP/PFI) in the inter...
01 October 2020 Rankings & Awards
We use cookies to offer better performance of the website and fulfill some other purposes specified in the Privacy Policy. By way of ticking the box you provide your consent to use of cookies. Otherwise, we will only use technical cookies, which are necessary for proper functioning of the website.
Accept